Veterans PTSD Screening Act
- Bill Number
- H.R. 3886
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Armed Forces and National Security
- Status
- Introduced
- Latest Action
- 2025-06-23: Referred to the Subcommittee on Health.
- Last Updated
- 2025-11-19T09:07:10Z
AI-Generated Summary
Purpose of the Legislation
The "Veterans PTSD Screening Act" (H.R. 3886) aims to improve the diagnosis of post-traumatic stress disorder (PTSD) in veterans by directing the Department of Veterans Affairs (VA) to study the potential use of RNA sequencing—a scientific technique that analyzes genetic material (RNA) in cells to detect changes like inflammation or stress—as a diagnostic tool for PTSD symptoms.
Key Provisions
- Study Establishment: Within 120 days of the bill's enactment, the VA Secretary must initiate the study through the VA's Center for Innovation for Care and Payment. The study will assess whether RNA sequencing can reliably identify PTSD-related symptoms, such as inflammation or cellular stress, in veterans.
- Implementation Details: The study will be conducted at medical facilities within five Veterans Integrated Service Networks (VISNs), which are regional groups of VA healthcare facilities across the U.S.
- Timeline: The study begins soon after enactment and ends on September 30, 2027.
- Reporting Requirement: By September 30, 2028, the VA Secretary must submit a report on the study's findings to the Senate and House Committees on Veterans' Affairs.
Significant Changes to Existing Law
This bill introduces a new mandate for the VA to conduct and fund a specific research study on RNA sequencing for PTSD diagnosis. It does not amend or repeal any existing laws but adds a targeted research obligation to the VA's responsibilities, potentially expanding its innovation and healthcare research programs.
Potential Impacts
- On Government Agencies: The VA will need to allocate resources, including staff and funding, for the study across multiple facilities, which could strain budgets but also advance its research capabilities in mental health.
- On Citizens: Veterans with PTSD may benefit from improved, more objective diagnostic methods if the study succeeds, leading to earlier detection and treatment. It could indirectly affect VA healthcare access for the estimated 20% of veterans who experience PTSD.
- On International Relations: No direct impacts, as the bill focuses solely on domestic VA operations and U.S. veterans.
Main Stakeholders Affected
- Veterans: Primary beneficiaries, particularly those seeking PTSD diagnosis and treatment through VA services.
- Department of Veterans Affairs (VA): Responsible for executing the study, including coordination across VISNs and reporting to Congress.
- Congressional Committees: The Senate and House Committees on Veterans' Affairs, which will receive the study results and may influence future VA policies based on them.
- Healthcare Researchers and Providers: VA-affiliated scientists and medical staff involved in the study, potentially extending to broader medical communities interested in RNA-based diagnostics.
Notable Legal, Constitutional, or Political Implications
- Legal: The bill is straightforward and complies with congressional authority over federal agencies like the VA; it imposes a clear, time-bound directive without creating new entitlements or liabilities.
- Constitutional: No significant issues, as it involves routine federal spending and research under Congress's spending power (Article I, Section 8 of the U.S. Constitution).
- Political: Highlights bipartisan support for veteran mental health (introduced by representatives from both parties), potentially signaling increased federal emphasis on innovative PTSD solutions amid ongoing veteran suicide and mental health crises. If successful, it could lead to broader legislative pushes for advanced diagnostics in public health.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Rep. Murphy, Gregory F. [R-NC-3]
Cosponsors (4)
Rep. Kiggans, Jennifer A. [R-VA-2], Del. King-Hinds, Kimberlyn [R-MP-At Large], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Bresnahan, Robert P. [R-PA-8]
Recent Actions
- 2025-06-23: Referred to the Subcommittee on Health.
- 2025-06-10: Referred to the House Committee on Veterans' Affairs.
- 2025-06-10: Introduced in House
- 2025-06-10: Introduced in House
Bill Versions
- Veterans PTSD Screening Act — issued 2025-06-10 — PDF (2 pages)